View Item 

Show simple item record

Diabetes in Older Adults: A Consensus Report

dc.contributor.authorSue Kirkman, M.en_US
dc.contributor.authorBriscoe, Vanessa Jonesen_US
dc.contributor.authorClark, Nathanielen_US
dc.contributor.authorFlorez, Hermesen_US
dc.contributor.authorHaas, Linda B.en_US
dc.contributor.authorHalter, Jeffrey B.en_US
dc.contributor.authorHuang, Elbert S.en_US
dc.contributor.authorKorytkowski, Mary T.en_US
dc.contributor.authorMunshi, Medha N.en_US
dc.contributor.authorOdegard, Peggy Souleen_US
dc.contributor.authorPratley, Richard E.en_US
dc.contributor.authorSwift, Carrie S.en_US
dc.date.accessioned2013-01-03T19:44:54Z
dc.date.available2014-01-07T14:51:09Zen_US
dc.date.issued2012-12en_US
dc.identifier.citationSue Kirkman, M.; Briscoe, Vanessa Jones; Clark, Nathaniel; Florez, Hermes; Haas, Linda B.; Halter, Jeffrey B.; Huang, Elbert S.; Korytkowski, Mary T.; Munshi, Medha N.; Odegard, Peggy Soule; Pratley, Richard E.; Swift, Carrie S. (2012). "Diabetes in Older Adults: A Consensus Report." Journal of the American Geriatrics Society 60(12): 2342-2356. <http://hdl.handle.net/2027.42/95492>en_US
dc.identifier.issn0002-8614en_US
dc.identifier.issn1532-5415en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/95492
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherU.S. Department of Health and Human Services, Centers for Disease Control and Preventionen_US
dc.titleDiabetes in Older Adults: A Consensus Reporten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23106132en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/95492/1/jgs12035.pdf
dc.identifier.doi10.1111/jgs.12035en_US
dc.identifier.sourceJournal of the American Geriatrics Societyen_US
dc.identifier.citedreferenceAmerican Geriatrics Society. Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 2012 ( 60 ): 616 – 631.en_US
dc.identifier.citedreferenceSchonberg MA, Davis RB, McCarthy EP et al. Index to predict 5‐year mortality of community‐dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med 2009; 24: 1115 – 1122.en_US
dc.identifier.citedreferenceWells BJ, Jain A, Arrigain S et al. Predicting 6‐year mortality risk in patients with type 2 diabetes. Diabetes Care 2008; 31: 2301 – 2306.en_US
dc.identifier.citedreferenceMcEwen LN, Kim C, Karter AJ et al. Risk factors for mortality among patients with diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2007; 30: 1736 – 1741.en_US
dc.identifier.citedreferenceHuang ES, Zhang Q, Gandra N et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med 2008; 149: 11 – 19.en_US
dc.identifier.citedreferenceKassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med 1994; 330: 1895 – 1896.en_US
dc.identifier.citedreferenceBarry MJ, Edgman‐Levitan S. Shared decision making—pinnacle of patient‐centered care. N Engl J Med 2012; 366: 780 – 781.en_US
dc.identifier.citedreferenceMontori VM, Gafni A, Charles C. A shared treatment decision‐making approach between patients with chronic conditions and their clinicians: The case of diabetes. Health Expect 2006; 9: 25 – 36.en_US
dc.identifier.citedreferenceHuang ES, Gorawara‐Bhat R, Chin MH. Self‐reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc 2005; 53: 306 – 311.en_US
dc.identifier.citedreferenceHuang ES, Brown SE, Ewigman BG et al. Patient perceptions of quality of life with diabetes‐related complications and treatments. Diabetes Care 2007; 30: 2478 – 2483.en_US
dc.identifier.citedreferenceBrown SE, Meltzer DO, Chin MH et al. Perceptions of quality‐of‐life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients. J Am Geriatr Soc 2008; 56: 1183 – 1190.en_US
dc.identifier.citedreferenceTsevat J, Dawson NV, Wu AW et al. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project. JAMA 1998; 279: 371 – 375.en_US
dc.identifier.citedreferenceTraylor AH, Subramanian U, Uratsu CS et al. Patient race/ethnicity and patient‐physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care 2010; 33: 520 – 525.en_US
dc.identifier.citedreferenceCommittee on Understanding Eliminating Racial Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (with CD). In: Smedley BD, Stith AY, Nelson AR, eds. Washington, DC: National Academies Press, 2003.en_US
dc.identifier.citedreferenceResnick HE, Heineman J, Stone R et al. Diabetes in U.S. nursing homes, 2004. Diabetes Care 2008; 31: 287 – 288.en_US
dc.identifier.citedreferenceMaurer MSBJ, Burcham J, Cheng H. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long‐term care facility. J Gerontol A Biol Sci Med Sci 2005; 60A: 1157 – 1162.en_US
dc.identifier.citedreferenceTravis SS, Buchanan RJ, Wang S et al. Analyses of nursing home residents with diabetes at admission. J Am Med Dir Assoc 2004; 5: 320 – 327.en_US
dc.identifier.citedreferenceDorner B, Friedrich EK; American Dietetic Association. Position of the American Dietetic Association: Individualized nutrition approaches for older adults in health care communities. J Am Diet Assoc 2010; 110: 1549 – 1553.en_US
dc.identifier.citedreferenceThomas DR, Cote TR, Lawhorne L et al. Dehydration Council. Understanding clinical dehydration and its treatment. J Am Med Dir Assoc 2008; 9: 292 – 301.en_US
dc.identifier.citedreferenceDonoghue C. Nursing home staff turnover and retention: An analysis of national level data. J Appl Gerontol 2010; 29: 89 – 106.en_US
dc.identifier.citedreferenceFeldman SM, Rosen R, DeStasio J. Status of diabetes management in the nursing home setting in 2008: A retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. J Am Med Dir Assoc 2009; 10: 354 – 360.en_US
dc.identifier.citedreferencePandya N, Thompson S, Sambamoorthi U. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. J Am Med Dir Assoc 2008; 9: 663 – 669.en_US
dc.identifier.citedreferenceMoghissi ES, Korytkowski MT, DiNardo M et al. American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119 – 1131.en_US
dc.identifier.citedreferenceUmpierrez GE, Hellman R, Korytkowski MT et al. Endocrine Society. Management of hyperglycemia in hospitalized patients in non‐critical care setting: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 16 – 38.en_US
dc.identifier.citedreferenceBlaum C, Cigolle CT, Boyd C et al. Clinical complexity in middle‐aged and older adults with diabetes: The Health and Retirement Study. Med Care 2010; 48: 327 – 334.en_US
dc.identifier.citedreferenceLaiteerapong NIJ, Iveniuk J, John PM et al. Classification of older adults who have diabetes by comorbid conditions, United States, 2005–2006. Prev Chronic Dis 2012; 9: E100.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011, p 2011.en_US
dc.identifier.citedreferenceBrown AF, Mangione CM, Saliba D et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51 ( Suppl. Guidelines ): S265 – S280.en_US
dc.identifier.citedreferenceSzoke E, Shrayyef MZ, Messing S et al. Effect of aging on glucose homeostasis: Accelerated deterioration of beta‐cell function in individuals with impaired glucose tolerance. Diabetes Care 2008; 31: 539 – 543.en_US
dc.identifier.citedreferenceChang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab 2003; 284: E7 – E12.en_US
dc.identifier.citedreferenceBoyle JP, Thompson TJ, Gregg EW et al. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010; 8: 29.en_US
dc.identifier.citedreferenceNarayan KM, Boyle JP, Geiss LS et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care 2006; 29: 2114 – 2116.en_US
dc.identifier.citedreferenceSelvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 2006; 29: 2415 – 2419.en_US
dc.identifier.citedreferenceLi Y, Burrows NR, Gregg EW et al. Declining rates of hospitalization for nontraumatic lower‐extremity amputation in the diabetic population aged 40 years or older: U.S., 1988–2008. Diabetes Care 2012; 35: 273 – 277.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Diabetes public health resource, Available at http://www.cdc.gov/diabetes Accessed September 27, 2012.en_US
dc.identifier.citedreferenceSchütt M, Fach EM, Seufert J et al. Multiple complications and frequent severe hypoglycaemia in ‘elderly’ and ‘old’ patients with type 1 diabetes. Diabet Med 2012; 29: e176 – e179.en_US
dc.identifier.citedreferenceAmati F, Dubé JJ, Coen PM et al. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 2009; 32: 1547 – 1549.en_US
dc.identifier.citedreferenceKnowler WC, Barrett‐Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393 – 403.en_US
dc.identifier.citedreferenceReers C, Erbel S, Esposito I et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol 2009; 160: 185 – 191.en_US
dc.identifier.citedreferenceMaedler K, Schumann DM, Schulthess F et al. Aging correlates with decreased beta‐cell proliferative capacity and enhanced sensitivity to apoptosis: A potential role for Fas and pancreatic duodenal homeobox‐1. Diabetes 2006; 55: 2455 – 2462.en_US
dc.identifier.citedreferenceRankin MM, Kushner JA. Adaptive β‐cell proliferation is severely restricted with advanced age. Diabetes 2009; 58: 1365 – 1372.en_US
dc.identifier.citedreferenceAmerican Diabetes Association. Standards of medical care in diabetes—2012 (Position Statement). Diabetes Care 2012; 35 ( Suppl. 1 ): S11 – S63.en_US
dc.identifier.citedreferenceCrandall J, Schade D, Ma Y et al. Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006; 61A: 1075 – 1081.en_US
dc.identifier.citedreferenceKnowler WC, Fowler SE, Hamman RF et al. Diabetes Prevention Program Research Group. 10‐year follow‐up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677 – 1686.en_US
dc.identifier.citedreferenceBrown JS, Wing R, Barrett‐Connor E et al. Diabetes Prevention Program Research Group. Lifestyle intervention is associated with lower prevalence of urinary incontinence: The Diabetes Prevention Program. Diabetes Care 2006; 29: 385 – 390.en_US
dc.identifier.citedreferenceFlorez H, Pan Q, Ackermann RT et al. for the Diabetes Prevention Program Research Group. Impact of lifestyle intervention and metformin on health‐related quality of life: the Diabetes Prevention Program Randomized Trial. J Gen Intern Med. June 13, 2012 [Epub ahead of print]en_US
dc.identifier.citedreferenceCrandall JP, Knowler WC, Kahn SE et al. Diabetes Prevention Program Research Group. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 382 – 393.en_US
dc.identifier.citedreferenceAckermann RT, Finch EA, Brizendine E et al. Translating the Diabetes Prevention Program into the community: The DEPLOY Pilot Study. Am J Prev Med 2008; 35: 357 – 363.en_US
dc.identifier.citedreferenceUK Prospective Diabetes Study (UKPDS) Group. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837 – 853.en_US
dc.identifier.citedreferenceUK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood‐glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854 – 865.en_US
dc.identifier.citedreferenceHolman RR, Paul SK, Bethel MA et al. 10‐year follow‐up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577 – 1589.en_US
dc.identifier.citedreferenceGerstein HC, Miller ME, Byington RP et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545 – 2559.en_US
dc.identifier.citedreferenceMiller ME, Bonds DE, Gerstein HC et al. ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340: b5444.en_US
dc.identifier.citedreferencePatel A, MacMahon S, Chalmers J et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560 – 2572.en_US
dc.identifier.citedreferenceDuckworth W, Abraira C, Moritz T et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129 – 139.en_US
dc.identifier.citedreferenceDuckworth WC, Abraira C, Moritz TE et al. Investigators of the VADT. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: The VA Diabetes Trial. J Diabetes Complications 2011; 25: 355 – 361.en_US
dc.identifier.citedreferenceSkyler JS, Bergenstal R, Bonow RO et al. American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009; 32: 187 – 192.en_US
dc.identifier.citedreferenceAraki A, Iimuro S, Sakurai T et al. Japanese Elderly Diabetes Intervention Trial Study Group. Long‐term multiple risk factor interventions in Japanese elderly diabetic patients: The Japanese Elderly Diabetes Intervention Trial—study design, baseline characteristics and effects of intervention. Geriatr Gerontol Int 2012; 12 ( Suppl. 1 ): 7 – 17.en_US
dc.identifier.citedreferenceCurrie CJ, Peters JR, Tynan A et al. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet 2010; 375: 481 – 489.en_US
dc.identifier.citedreferenceHuang ES, Liu JY, Moffet HH et al. Glycemic control, complications, and death in older diabetic patients: The Diabetes and Aging Study. Diabetes Care 2011; 34: 1329 – 1336.en_US
dc.identifier.citedreferencePiette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006; 29: 725 – 731.en_US
dc.identifier.citedreferenceLaiteerapong N, Huang ES, Chin MH. Prioritization of care in adults with diabetes and comorbidity. Ann N Y Acad Sci 2011; 1243: 69 – 87.en_US
dc.identifier.citedreferenceGreenfield S, Billimek J, Pellegrini F et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: A cohort study. Ann Intern Med 2009; 151: 854 – 860.en_US
dc.identifier.citedreferenceCollins R, Armitage J. High‐risk elderly patients PROSPER from cholesterol‐lowering therapy. Lancet 2002; 360: 1618 – 1619.en_US
dc.identifier.citedreferenceShepherd J, Blauw GJ, Murphy MB et al. PROSPER (PROspective Study of Pravastatin in the Elderly at Risk) study group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002; 360: 1623 – 1630.en_US
dc.identifier.citedreferenceLipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild‐to‐moderate renal insufficiency. Diabetes Care 2011; 34: 1431 – 1437.en_US
dc.identifier.citedreferenceBaigent C, Keech A, Kearney PM et al. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol‐lowering treatment: Prospective meta‐analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267 – 1278.en_US
dc.identifier.citedreferenceCigolle CT, Blaum CS, Halter JB. Diabetes and cardiovascular disease prevention in older adults. Clin Geriatr Med 2009; 25: 607 – 641, vii–viii.en_US
dc.identifier.citedreferenceGinsberg HN, Elam MB, Lovato LC et al. ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1563 – 1574.en_US
dc.identifier.citedreferenceKeech A, Simes RJ, Barter P et al. FIELD study investigators. Effects of long‐term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet 2005; 366: 1849 – 1861.en_US
dc.identifier.citedreferenceHansson L, Zanchetti A, Carruthers SG et al. HOT Study Group. Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755 – 1762.en_US
dc.identifier.citedreferenceCushman WC, Evans GW, Byington RP et al. ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575 – 1585.en_US
dc.identifier.citedreferenceCooper‐DeHoff RM, Gong Y, Handberg EM et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304: 61 – 68.en_US
dc.identifier.citedreferenceAnderson RJ, Bahn GD, Moritz TE et al. VADT Study Group. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care 2011; 34: 34 – 38.en_US
dc.identifier.citedreferenceBaigent C, Blackwell L, Collins R et al. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta‐analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849 – 1860.en_US
dc.identifier.citedreferenceOgawa H, Nakayama M, Morimoto T et al. Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low‐dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trial. JAMA 2008; 300: 2134 – 2141.en_US
dc.identifier.citedreferenceHernández‐Díaz S. García Rodríguez LA. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med 2006; 4: 22.en_US
dc.identifier.citedreferenceDe Berardis G, Lucisano G, D'Ettorre A et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 2012; 307: 2286 – 2294.en_US
dc.identifier.citedreferenceAbraham NS, Hlatky MA, Antman EM et al. ACCF/ACG/AHA. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 2010; 2010 ( 105 ): 2533 – 2549.en_US
dc.identifier.citedreferenceLi R, Zhang P, Barker LE et al. Cost‐effectiveness of interventions to prevent and control diabetes mellitus: A systematic review. Diabetes Care 2010; 33: 1872 – 1894.en_US
dc.identifier.citedreferenceAgardh E, Tababat‐Khani P. Adopting 3‐year screening intervals for sight‐threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 2011; 34: 1318 – 1319.en_US
dc.identifier.citedreferenceUnited States Department of Veterans Affairs. VA/DOD clinical practice guidelines: Management of diabetes mellitus in primary care, 2010. Available at http://www.healthquality.va.gov/Diabetes_Mellitus.asp Accessed September 27, 2012.en_US
dc.identifier.citedreferenceSinclair AJ, Paolisso G, Castro M et al. Rodriguez Mañas L; European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus: Executive summary. Diabetes Metab 2011; 37 ( Suppl. 3 ): S27 – S38.en_US
dc.identifier.citedreferenceLaiteerapong N, Karter AJ, Liu JY et al. Correlates of quality of life in older adults with diabetes: The Diabetes & Aging Study. Diabetes Care 2011; 34: 1749 – 1753.en_US
dc.identifier.citedreferenceLu FP, Lin KP, Kuo HK. Diabetes and the risk of multi‐system aging phenotypes: A systematic review and meta‐analysis. PLoS ONE 2009; 4: e4144.en_US
dc.identifier.citedreferencePunthakee Z, Miller ME, Launer LJ et al. ACCORD Group of Investigators; ACCORD‐MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012; 35: 787 – 793.en_US
dc.identifier.citedreferenceLauner LJ, Miller ME, Williamson JD et al. ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open‐label substudy. Lancet Neurol 2011; 10: 969 – 977.en_US
dc.identifier.citedreferenceCukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 2005; 48: 2460 – 2469.en_US
dc.identifier.citedreferenceWhitmer RA, Karter AJ, Yaffe K et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301: 1565 – 1572.en_US
dc.identifier.citedreferenceGregg EW, Mangione CM, Cauley JA et al. Study of Osteoporotic Fractures Research Group. Diabetes and incidence of functional disability in older women. Diabetes Care 2002; 25: 61 – 67.en_US
dc.identifier.citedreferenceGregg EW, Sorlie P, Paulose‐Ram R et al. Prevalence of lower‐extremity disease in the U.S. adult population ≥ 40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 1591 – 1597.en_US
dc.identifier.citedreferenceRichardson JK, Thies SB, DeMott TK et al. Gait analysis in a challenging environment differentiates between fallers and nonfallers among older patients with peripheral neuropathy. Arch Phys Med Rehabil 2005; 86: 1539 – 1544.en_US
dc.identifier.citedreferenceRichardson JK, Thies S, Ashton‐Miller JA. An exploration of step time variability on smooth and irregular surfaces in older persons with neuropathy. Clin Biomech (Bristol, Avon) 2008; 23: 349 – 356.en_US
dc.identifier.citedreferenceMenz HB, Lord SR. St George R, Fitzpatrick RC. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. Arch Phys Med Rehabil 2004; 85: 245 – 252.en_US
dc.identifier.citedreferenceVolpato S, Blaum C, Resnick H et al. Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women's Health and Aging Study. Diabetes Care 2002; 25: 678 – 683.en_US
dc.identifier.citedreferenceVolpato S, Leveille SG, Blaum C et al. Risk factors for falls in older disabled women with diabetes: The Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 2005; 60A: 1539 – 1545.en_US
dc.identifier.citedreferenceSchwartz AV, Hillier TA, Sellmeyer DE et al. Older women with diabetes have a higher risk of falls: A prospective study. Diabetes Care 2002; 25: 1749 – 1754.en_US
dc.identifier.citedreferenceThe American Geriatrics Society. AGS/BGS clinical practice guideline: Prevention of falls in older persons, 2010. Available at http://www.americangeriatrics.org/health_care_professionals/clinical_practice/clinical_guidelines_recommendations//2010/ Accessed September 27, 2012.en_US
dc.identifier.citedreferenceDailey G. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Clin Ther 2011; 33: 665 – 678.en_US
dc.identifier.citedreferenceFulton MM, Allen ER. Polypharmacy in the elderly: A literature review. J Am Acad Nurse Pract 2005; 17: 123 – 132.en_US
dc.identifier.citedreferenceHuang ES, Karter AJ, Danielson KK et al. The association between the number of prescription medications and incident falls in a multi‐ethnic population of adult type‐2 diabetes patients: The Diabetes and Aging Study. J Gen Intern Med 2010; 25: 141 – 146.en_US
dc.identifier.citedreferenceNouwen A, Winkley K, Twisk J et al. European Depression in Diabetes (EDID) Research Consortium. Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and meta‐analysis. Diabetologia 2010; 53: 2480 – 2486.en_US
dc.identifier.citedreferenceLin EH, Katon W, Von Korff M et al. Relationship of depression and diabetes self‐care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154 – 2160.en_US
dc.identifier.citedreferenceKaton W, Lyles CR, Parker MM et al. Association of depression with increased risk of dementia in patients with type 2 diabetes: The Diabetes and Aging Study. Arch Gen Psychiatry 2012; 69: 410 – 417.en_US
dc.identifier.citedreferenceKaton WJ, Rutter C, Simon G et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28: 2668 – 2672.en_US
dc.identifier.citedreferenceMontorio I, Izal M. The Geriatric Depression Scale: A review of its development and utility. Int Psychogeriatr 1996; 8: 103 – 112.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Vision Health Initiative. Available at http://www.cdc.gov/visionhealth/data/index.htm Accessed September 27, 2012.en_US
dc.identifier.citedreferenceBainbridge KE, Hoffman HJ, Cowie CC. Diabetes and hearing impairment in the United States: Audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med 2008; 149: 1 – 10.en_US
dc.identifier.citedreferenceBainbridge KE, Hoffman HJ, Cowie CC. Risk factors for hearing impairment among U.S. adults with diabetes: National Health and Nutrition Examination Survey 1999–2004. Diabetes Care 2011; 34: 1540 – 1545.en_US
dc.identifier.citedreferenceMiller CKEL, Edwards L, Kissling G et al. Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: Results from a randomized controlled trial. Prev Med 2002; 34: 252 – 259.en_US
dc.identifier.citedreferenceVillareal DT, Banks M, Siener C et al. Physical frailty and body composition in obese elderly men and women. Obes Res 2004; 12: 913 – 920.en_US
dc.identifier.citedreferenceVillareal DT, Banks M, Sinacore DR et al. Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med 2006; 166: 860 – 866.en_US
dc.identifier.citedreferenceMiller SL, Wolfe RR. The danger of weight loss in the elderly. J Nutr Health Aging 2008; 12: 487 – 491.en_US
dc.identifier.citedreferenceShapses SA, Riedt CS. Bone, body weight, and weight reduction: What are the concerns? J Nutr 2006; 136: 1453 – 1456.en_US
dc.identifier.citedreferenceSuhl E, Bonsignore P. Diabetes self‐management education for older adults: General principles and practical application. Diabetes Spectrum 2006; 19: 234 – 240.en_US
dc.identifier.citedreferencePark SW, Goodpaster BH, Strotmeyer ES et al. Decreased muscle strength and quality in older adults with type 2 diabetes: The Health, Aging, and Body Composition Study. Diabetes 2006; 55: 1813 – 1818.en_US
dc.identifier.citedreferenceVillareal DT, Chode S, Parimi N et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 2011; 364: 1218 – 1229.en_US
dc.identifier.citedreferenceJakicic JM, Jaramillo SA, Balasubramanyam A et al. Look AHEAD Study Group. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: Results from the Look AHEAD Study. Int J Obes (Lond) 2009; 33: 305 – 316.en_US
dc.identifier.citedreferenceBuman MP, Hekler EB, Haskell WL et al. Objective light‐intensity physical activity associations with rated health in older adults. Am J Epidemiol 2010; 172: 1155 – 1165.en_US
dc.identifier.citedreferenceShorr RI, Ray WA, Daugherty JR et al. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44: 751 – 755.en_US
dc.identifier.citedreferenceInzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: A patient‐centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364 – 1379.en_US
dc.identifier.citedreferenceNational Institute for Health and Clinical Excellence. The management of type 2 diabetes: 2010 NICE guidelines. Available at http://www.nice.org.uk/nicemedia/live/12165/44320/44320.pdf Accessed September 27, 2012.en_US
dc.identifier.citedreferenceHerman WH, Ilag LL, Johnson SL et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28: 1568 – 1573.en_US
dc.identifier.citedreferenceLee P, Chang A, Blaum C et al. Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: Results from a pooled analysis. J Am Geriatr Soc 2012; 60: 51 – 59.en_US
dc.identifier.citedreferenceMatyka K, Evans M, Lomas J et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997; 20: 135 – 141.en_US
dc.identifier.citedreferenceBremer JP, Jauch‐Chara K, Hallschmid M et al. Hypoglycemia unawareness in older compared with middle‐aged patients with type 2 diabetes. Diabetes Care 2009; 32: 1513 – 1517.en_US
dc.identifier.citedreferenceShorr RI, Ray WA, Daugherty JR et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681 – 1686.en_US
dc.identifier.citedreferenceZammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28: 2948 – 2961.en_US
dc.identifier.citedreferenceArias E. United States life tables, 2007. Natl Vital Stat Rep 2011; 59: 1 – 60.en_US
dc.identifier.citedreferenceYourman LC, Lee SJ, Schonberg MA et al. Prognostic indices for older adults: A systematic review. JAMA 2012; 307: 182 – 192.en_US
dc.identifier.citedreferenceLee SJ, Lindquist K, Segal MR et al. Development and validation of a prognostic index for 4‐year mortality in older adults. JAMA 2006; 295: 801 – 808.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgs12035.pdf
Size:
154.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.